EMA Authorised: Telmisartan Actavis (telmisartan) — Actavis Group PTC ehf

View source ↗

Summary

Telmisartan Actavis has been authorised for the treatment of hypertension in the EU.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Drugs mentioned

• Telmisartan Actavis (telmisartan)

Snippet

Status: Authorised. Therapeutic area: Hypertension. MAH: Actavis Group PTC ehf. Decision date: 07/07/2026